Abu Dhabi: SEHA or the Abu Dhabi Health Services Company has entered into a partnership with Kahn-Sagol-Maccabi (KSM), the research and innovation centre of Israel’s Maccabi Healthcare Services to promote joint medical research and technological innovation.
Signed on 29th June in Abu Dhabi, the agreement will also support Abu Dhabi’s ambitions of building a genomic research registry to optimize clinical data, sample collection and clinical reporting.
The collaboration focuses on promoting medical research that combines big data capabilities and genetic and clinical research with the goal of advancing personalized medicine, while emphasizing medical innovation and the establishment of a regional ecosystem that will support joint research activities. Studies will be conducted in cancer, cardiovascular disease, diabetes and more.
This partnership supports SEHA’s vision and objectives of exploring collaboration opportunities in other areas that foster cooperation in education, research, health technology, and clinical programs. We look forward to a successful partnership and extending this program to our facilities and distinguished practitioners.
Mr. Saeed Al Kuwaiti, Group CEO of SEHA remarked about the partnership.
Meanwhile, Dr. Tal Patalon, Head of KSM, stated that, “We continue to build research collaborations with various countries in the region, implementing our vision of a shared innovative ecosystem that promotes research and development of advanced personalized medicine, while creating added value within the whole region.”
For his part, Dr. Ghanem Ali Al Hassani, Conference Chairman and SEHA’s Group Education and Research Director, observed that, “We are pleased to announce this signing with Kahn-Sagol-Maccabi, as the agreement will contribute to strengthening our cooperation in scientific research, genomic exploration and knowledge exchange to accelerate economic growth and human progress.”